GlassScriptPhysician profile
Tiffany Tseng
NPI 1225411788
$1,279.11
in general payments reported to CMS, 2019-2025
15 companies · $594 in 2025
The $594 reported for 2025 was more than what 81% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $120 · 2021: $24.58 · 2022: $229 · 2023: $142 · 2024: $170 · 2025: $594.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $905.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $905.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $194.29 | 2023-2025 | Vuity, Lumigan, Alphagan P |
| Bausch & Lomb Americas INC. | $190.62 | 2024-2025 | Envista Envy Iol, Envista Mx60 Iol, Vyzulta |
| Tarsus Pharmaceuticals, INC. | $168.41 | 2025 | Xdemvy |
| Sun Pharmaceutical Industries INC. | $155.56 | 2019-2022 | |
| Dompe US, INC. | $100.62 | 2022-2025 | Oxervate |
| Revance Therapeutics, INC. | $77.11 | 2025 | Daxxify |
| Biotissue Holdings INC. | $57.74 | 2022-2025 | |
| Johnson & Johnson Surgical Vision, INC. | $56.72 | 2024-2025 | Tecnis Iol, Tecnis Simplicity |
| Alcon Vision LLC | $53.98 | 2024-2025 | Rocklatan |
| Johnson & Johnson Vision Care, INC. | $50.04 | 2019-2021 | |
| Rxsight INC | $48.30 | 2023-2025 | Rxsight Injector Handpiece, Rxsight Contact Lens, Rxsight Light Delivery Device (Ldd) |
| Alcon Research LLC | $42.76 | 2019 | |
| Shire North American Group INC | $38.98 | 2019 | |
| Oyster Point Pharma, INC. | $25.19 | 2022 | |
| Glaukos Corporation | $18.79 | 2025 | Kxl System (Not Refurbished) |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tiffany Tseng listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.